| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |